The main gene mutations in PDAC are KRAS genes, which are mutated in more than 90% of patients, and some tumour suppressor genes such as CDKN2, TP53, and SMAD4 in approximately 90%, 60%, and 55% of PDAC cases, respectively [8,44]. This evidence concerns the gene KRAS and neoplasm.